Skip to main content
. 2022 Aug 24;12:916906. doi: 10.3389/fonc.2022.916906

Table 1.

Clinical and follow-up data of 31 patients with pulmonary mucoepidermoid carcinoma.

Number Total (n=31) Low grade (n=25) High grade (n=6) P value
Sex (male/female) 23/8 20/5 3/3 0.132
Age 60.77 ± 11.44 60.280 ± 12.337 62.833 ± 6.998 0.632
Location
 upper left lung 9 (29%) 7 (28%) 2 (33.3%) 0.382
 lower left lung 3 (9.6%) 3 (12%) 0 (0%)
 right-sided pleura 1 (3.2%) 1 (4%) 0 (0%)
 upper right lung 7 (22.6%) 4 (16%) 3 (50%)
 lower right lung 7 (22.6%) 7 (28%) 0 (0%)
 middle right lung 5 (16.1%) 4 (16%) 1 (16.7%)
Symptoms
 cough 21 (67.7%) 18 (72%) 3 (50%) 0.301
 bloody sputum 9 (29%) 6 (66.7%) 3 (50%) 0.208
 haemoptysis 5 (16.1%) 4 (16%) 1 (16.7%) 0.968
 chest tightness 5 (16.1) 5 (20%) 0 (0%) 0.232
 fever 1 (3.2%) 1 (4%) 0 (0%) 0.618
 chest pain 6 (19.4%) 4 (16%) 2 (33.3%) 0.335
 hoarseness 2 (6.5%) 2 (8%) 0 (0%) 0.474
Smoking history 16 (51/6%) 14 (56%) 3 (50%) 0.791
History of alcoholism 10 (32.3%) 8 (32%) 2 (33.3%) 0.95
Family history of tumours 4 (12.9%) 3 (12%) 1 (16.7%) 0.759
History of allergy 1 (3.2%) 1 (4%) 0 (0%) 0.618
TNM stage
 I 10 (32.3%) 9 (36%) 1 (16.7%) 0.359
 II 5 (16.1) 5 (20%) 0 (0%)
 III 3 (9.6%) 2 (8%) 1 (16.7%)
 IV 13 (41.9%) 9 (36%) 4 (66.7%)
Imaging characteristics
 Intratubular type 11 (35.5%) 9 (36%) 2 (33.3%) 0.902
 Space-occupying lesions 28 (90.3%) 22 (88%) 6 (100%) 0.372
 Obstructive atelectasis 11 (35.5%) 10 (40%) 1 (16.7%) 0.283
Prognostic information
 Recurrence 4 (22.2%) (n=18) 2 (8%) (n=16) 2 (100%) (n=2) 0.005
 Metastasis 12 (100%) (n=12) 10 (32.3%) (n=16) 2 (100%) (n=2) 0.383
 Death 9 (29%) 4 (16%) 5 (83.3%) 0.001

Red text means the value is significant.